Ozempic ‘microdosing’ is new weight-loss trend

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...
PGC-1α research offers new hope for weight loss by boosting metabolic efficiency and providing accessible management ...
In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers found. Common adverse side effects from the drugs included nausea, vomiting, ...
New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.
So many people are now taking medication that the inexorable rise in obesity could start to reverse, one of the biggest ...
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...